We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Import and export (28)
- Safety monitoring and information (121)
- Compliance and enforcement (32)
- Shortages and supply disruptions (17)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
489 result(s) found, displaying 226 to 250
-
Safety alertsJa Dera 100% Natural Weight Loss Supplement capsules pose a serious risk to your health and should not be taken
-
Safety alertsNo evidence to support routine blood monitoring at this time
-
Safety alertsSlim Fit capsules pose a serious risk to your health and should not be taken
-
Market actionsRecall - risk of adverse events due to unacceptably high level of arsenic
-
Safety alertsUpdate - adverse event monitoring
-
Market actionsThe following medicines (with brand names in brackets) should be returned to a pharmacy: alprazolam (Xanax), cabergoline (Dostinex and Cabaser), mefanamic acid (Ponstan), methotrexate (Methoblastin) and triazolam (Halcion)
-
Market actionsRecall - bottles supplied without child-resistant caps
-
-
-
-
-
-
-
-
-
-
-
-
Safety alertsSafety advisory
-
-
Market actionsRecall for product correction - bottles supplied without child-resistant caps
-
Market actionsRecall - bottles supplied without child-resistant caps
-
Market actionsRecall for product correction - bottles supplied without child-resistant caps
-
Market actionsRecall - bottles supplied without child-resistant caps
-
Market actionsRecall - bottles supplied without child-resistant caps